AJ

Alpesh Jamanaprasad Shrivas

Active Director Director DIN 09346750
DIN 09346750 First appointment Oct 2021 Primary industry Healthcare
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Oct 2021
Shareholding value β€’β€’β€’β€’ Premium profile

About Alpesh Jamanaprasad Shrivas

Data last updated:

Alpesh Jamanaprasad Shrivas is a Director at Redman Pharmaceuticals Private Limited (since 2021). The company operates in Healthcare.

DIN 09346750
Primary Designation Director
Industry Healthcare
First Appointment 05 Oct 2021
Oldest Company Age 5 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director05 Oct 20212021Active

Board colleagues of Alpesh Jamanaprasad Shrivas

Directorship timeline

Open interactive timeline →
Redman Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Alpesh Jamanaprasad Shrivas

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Alpesh Jamanaprasad Shrivas

Alpesh Jamanaprasad Shrivas currently holds 1 directorship: Redman Pharmaceuticals Private Limited (Director, since 05 Oct 2021).

Alpesh Jamanaprasad Shrivas was first appointed on 05 Oct 2021 as Director at Redman Pharmaceuticals Private Limited.

The current boards of Alpesh Jamanaprasad Shrivas's companies include Chandra Prakash Shrivas (Redman Pharmaceuticals Private Limited), Deepika Alpesh Shrivas (Redman Pharmaceuticals Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available